A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade glioma.
A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade glioma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab003.